Lyell Immunopharma (LYEL) News Today $9.24 -0.28 (-2.94%) Closing price 07/18/2025 04:00 PM EasternExtended Trading$9.56 +0.32 (+3.46%) As of 07/18/2025 04:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock LYEL Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Lyell Immunopharma (NASDAQ:LYEL) Stock Price Down 5.9% - What's Next?July 16 at 3:42 AM | marketbeat.comLyell Immunopharma, Inc. (LYEL) Balance Sheet - Yahoo FinanceJuly 15, 2025 | finance.yahoo.comLyell Immunopharma (NASDAQ:LYEL) Stock Price Expected to Rise, HC Wainwright Analyst SaysJune 24, 2025 | marketbeat.comLyell Immunopharma (NASDAQ:LYEL) Trading 3.5% Higher - What's Next?June 24, 2025 | marketbeat.comLyell Immunopharma to Participate in the H.C. Wainwright "HCW@Home" SeriesJune 23, 2025 | tmcnet.comLyell Immunopharma to Participate in the H.C. Wainwright “HCW@Home” SeriesJune 23, 2025 | globenewswire.comLyell reports new clinical data from trial of large B-cell lymphoma therapyJune 18, 2025 | finance.yahoo.comLyell Immunopharma Announces Positive New Clinical Data Demonstrating High Rates of Durable Complete Responses from the Phase 1/2 Trial of LYL314 for the Treatment of Aggressive Large B-cell LymphomaJune 17, 2025 | globenewswire.comShort Interest in Lyell Immunopharma, Inc. (NASDAQ:LYEL) Drops By 94.5%June 11, 2025 | marketbeat.comLyell Immunopharma Taps Shook as Chief Medical OfficerJune 11, 2025 | marketwatch.comLyell Immunopharma Strengthens Clinical and Commercial Capabilities with Key Board and Executive AppointmentsJune 9, 2025 | globenewswire.comLyell Immunopharma (NASDAQ:LYEL) Upgraded by Wall Street Zen to "Hold" RatingJune 6, 2025 | marketbeat.comLyell Immunopharma to Participate in the Goldman Sachs Global Healthcare ConferenceJune 4, 2025 | globenewswire.comLyell Immunopharma (NASDAQ:LYEL) Shares Up 14.7% - Should You Buy?June 4, 2025 | marketbeat.comLyell Immunopharma (NASDAQ:LYEL) Hits New 52-Week Low - Here's What HappenedJune 2, 2025 | marketbeat.comShort Interest in Lyell Immunopharma, Inc. (NASDAQ:LYEL) Expands By 71.6%June 1, 2025 | marketbeat.comLyell Immunopharma trading halted, news pendingMay 31, 2025 | msn.comvenBio Partners LLC Makes New Investment in Lyell Immunopharma, Inc. (NASDAQ:LYEL)May 22, 2025 | marketbeat.comJacobs Levy Equity Management Inc. Acquires New Holdings in Lyell Immunopharma, Inc. (NASDAQ:LYEL)May 19, 2025 | marketbeat.comLyell Immunopharma, Inc: Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2025May 17, 2025 | finanznachrichten.deOrbimed Advisors LLC Decreases Stock Position in Lyell Immunopharma, Inc. (NASDAQ:LYEL)May 15, 2025 | marketbeat.comLyell Immunopharma Advances CAR T-Cell Therapy PipelineMay 13, 2025 | tipranks.comLyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2025May 13, 2025 | globenewswire.comForesite Capital Management V LLC Invests $5.21 Million in Lyell Immunopharma, Inc. (NASDAQ:LYEL)May 12, 2025 | marketbeat.comAlmitas Capital LLC Takes Position in Lyell Immunopharma, Inc. (NASDAQ:LYEL)May 4, 2025 | marketbeat.comRenaissance Technologies LLC Purchases 1,414,746 Shares of Lyell Immunopharma, Inc. (NASDAQ:LYEL)May 3, 2025 | marketbeat.comLyell Immunopharma Announces Oral Presentation of New Clinical Data from the Phase 1/2 Trial of LYL314 for the Treatment of Large B-cell Lymphoma at the International Conference on Malignant Lymphoma (ICML) 2025May 1, 2025 | globenewswire.comLyell Immunopharma (LYEL) Projected to Post Earnings on MondayApril 30, 2025 | marketbeat.comDecheng Capital LLC Invests $7.62 Million in Lyell Immunopharma, Inc. (NASDAQ:LYEL)April 28, 2025 | marketbeat.comJohnson & Johnson Buys Shares of 823,317 Lyell Immunopharma, Inc. (NASDAQ:LYEL)April 22, 2025 | marketbeat.comLyell Immunopharma (NASDAQ:LYEL) Earns Neutral Rating from HC WainwrightApril 18, 2025 | marketbeat.comLyell Immunopharma announces FDA granted RMAT designation to LYL314April 17, 2025 | markets.businessinsider.comLyell Immunopharma Receives Regenerative Medicine Advanced Therapy (RMAT) Designation for LYL314 for the Treatment of Relapsed and/or Refractory Large B-Cell LymphomaApril 15, 2025 | globenewswire.comInsider Buying: Lyell Immunopharma, Inc. (NASDAQ:LYEL) Director Purchases 35,640 Shares of StockApril 4, 2025 | marketbeat.comOtis W. Brawley Buys 35,640 Shares of Lyell Immunopharma, Inc. (NASDAQ:LYEL) StockApril 3, 2025 | insidertrades.comLyell Immunopharma, Inc. (NASDAQ:LYEL) Short Interest UpdateMarch 31, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Has $1.05 Million Holdings in Lyell Immunopharma, Inc. (NASDAQ:LYEL)March 31, 2025 | marketbeat.comBank of America Securities Keeps Their Sell Rating on Lyell Immunopharma (LYEL)March 28, 2025 | markets.businessinsider.comIs Lyell Immunopharma, Inc. (LYEL) the Cheapest Stock Insiders Are Buying In March?March 28, 2025 | insidermonkey.comTakeda Pharmaceutical Co. Ltd. Acquires Shares of 823,317 Lyell Immunopharma, Inc. (NASDAQ:LYEL)March 28, 2025 | marketbeat.comLyell Immunopharma, Inc. (NASDAQ:LYEL) Director Sumant Ramachandra Purchases 200,000 SharesMarch 26, 2025 | marketbeat.comFavourable Signals For Lyell Immunopharma: Numerous Insiders Acquired StockMarch 20, 2025 | finance.yahoo.comInsider Buying: Lyell Immunopharma, Inc. (NASDAQ:LYEL) Director Buys 158,000 Shares of StockMarch 19, 2025 | marketbeat.comCharles W. Newton Acquires 200,000 Shares of Lyell Immunopharma, Inc. (NASDAQ:LYEL) StockMarch 19, 2025 | marketbeat.comLynn Seely Buys 175,000 Shares of Lyell Immunopharma, Inc. (NASDAQ:LYEL) StockMarch 19, 2025 | marketbeat.comShort Interest in Lyell Immunopharma, Inc. (NASDAQ:LYEL) Declines By 16.2%March 19, 2025 | marketbeat.comLyell Immunopharma, Inc. (NASDAQ:LYEL) Director Richard Klausner Purchases 158,000 SharesMarch 19, 2025 | insidertrades.comHC Wainwright Has Optimistic Outlook of LYEL Q1 EarningsMarch 17, 2025 | marketbeat.comLyell Immunopharma (NASDAQ:LYEL) Receives Neutral Rating from HC WainwrightMarch 14, 2025 | marketbeat.comLyell Immunopharma (NASDAQ:LYEL) Issues Quarterly Earnings ResultsMarch 12, 2025 | marketbeat.com Get Lyell Immunopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for LYEL and its competitors with MarketBeat's FREE daily newsletter. Email Address LYEL Media Mentions By Week LYEL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LYEL News Sentiment▼-0.440.57▲Average Medical News Sentiment LYEL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LYEL Articles This Week▼22▲LYEL Articles Average Week Get Lyell Immunopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for LYEL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ATAI News TYRA News OPT News BCYC News KURA News PRME News TSHA News BCAX News ABVX News PGEN News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LYEL) was last updated on 7/19/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lyell Immunopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lyell Immunopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.